PDB58 WHAT IS THE IMPACT OF GENERIC SUBSTITUTION OF ROSIGLITAZONE ON PATIENT OUTCOMES AND TREATMENT COSTS? AN HMO EXPERIENCE

May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.566
https://www.valueinhealthjournal.com/article/S1098-3015(11)00705-4/fulltext
Section Title : Disease-Specific Studies
Section Order : 20
First Page : A101
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00705-4&doi=10.1016/j.jval.2011.02.566
HEOR Topics :
Tags :
Regions :